These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
868 related articles for article (PubMed ID: 31203996)
1. Venetoclax-based therapies for acute myeloid leukemia. Guerra VA; DiNardo C; Konopleva M Best Pract Res Clin Haematol; 2019 Jun; 32(2):145-153. PubMed ID: 31203996 [TBL] [Abstract][Full Text] [Related]
2. New drugs creating new challenges in acute myeloid leukemia. Tiong IS; Wei AH Genes Chromosomes Cancer; 2019 Dec; 58(12):903-914. PubMed ID: 30861214 [TBL] [Abstract][Full Text] [Related]
3. Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML. Wei AH; Tiong IS Blood; 2017 Dec; 130(23):2469-2474. PubMed ID: 29051180 [TBL] [Abstract][Full Text] [Related]
4. What to use to treat AML: the role of emerging therapies. Thol F Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):16-23. PubMed ID: 34889359 [TBL] [Abstract][Full Text]